Study S000865

Effect of Exenatide in Obese Patients With Accelerated Gastric Emptying

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

Included trial: extracted data ClinicalTrials.gov record

Registration

Registration: NCT02160990
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE4
Masking: QUADRUPLE
Status: COMPLETED
Enrollment: 20
Start: 2014-06
Primary completion: 2015-03
Lead sponsor: Mayo Clinic
Conditions: Obesity
Interventions: DRUG:Exenatide; DRUG:Placebo
Results posted: TRUE
Individual participant data sharing: NO
Secondary identifiers: NIH:R01DK067071; NIH:UL1TR000135

Registered primary outcomes

Gastric Emptying Half-time (T 1/2) of Solids [time frame is 30 days after the initiation of dose.]

Linked records (1)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

Record	Title	Year	Design	Identifiers	Link basis
R0020690	Exenatide in obesity with accelerated gastric emptying: a randomized, pharmacodynamics study. Acosta A, Physiological reports	2015	Randomized trial	PMID 26542264 DOI	registry reference RESULT:26542264